A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants

Pediatric Diabetes

Volumn 12, Issue 2, 2011, Pages 85-90

  Sosenko, Jay M ^a   Mahon, Jeffrey ^b   Rafkin, Lisa ^a   Lachin, John M ^c   Krause Steinrauf, Heidi ^c   Krischer, Jeffrey P ^d   Cuthbertson, David ^d   Palmer, Jerry P ^e   Thompson, Clinton ^c   Greenbaum, Carla J ^f   Skyler, Jay S ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

C peptide; Glucose; Prevention; T1D; Trials

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCOSE; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; CHILD; DIABETES MELLITUS; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AUTOANTIBODIES; BASAL METABOLISM; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; MALE; MASS SCREENING; METABOLOME; MIDDLE AGED; YOUNG ADULT;

EID: 79951974384     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00662.x     Document Type: Article

References (17)

1. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974: 2: 1279-1282.
2. Lendrum R, Walker G, Cudworth AG et al. Islet-cell antibodies in diabetes mellitus. Lancet 1976: 2: 1273-1276.
3. Gorsuch AN, Spencer KM, Lister J et al. Evidence for a long prediabetic period in type I (insulin dependent) diabetes mellitus. Lancet 1981: 2: 1363-1365.
4. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983: 222: 1337-1339.
5. Wilkin T, Armitage M, Casey C et al. Value of insulin autoantibodies as serum markers for insulin- dependent diabetes mellitus. Lancet 1985: 480-481.
6. Baekkeskov S, Landin M, Kristensen JK et al. Antibodies to a 64 000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987: 79: 926-934.
7. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 1990: 172: 789-794.
8. Payton MA, Hawkes CJ, Christie MR. Relationship of 37 000 and 40 000-M triptic fragment of islet antigens in insulin dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2(ICA 512). J Clin Invest 1995: 96: 1506-1511.
9. Verge CF, Gianani R, Kawasaki E et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun 1996: 9: 379-383.
10. Kulmala P, Savola K, Petersen JS et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 1998: 101: 327-336.
11. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002: 346: 1685-1691.
12. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes. Diabetes Care 2005: 28: 1068-1076.
13. Gale EA, Bingley PJ, Emmett CL et al. A randomized controlled trial of intervention before the onset of type 1. Lancet 2004: 363: 925-931.
14. Mahon JL, Sosenko JM, Rafkin-Mervis L et al. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 2009: 10: 97-104.
15. Sosenko JM, Krischer JP, Palmer JP et al. Diabetes Prevention Trial-Type 1 Study Group: a risk score for type 1 diabetes derived from autoantibody positive participants in The Diabetes Prevention Trial-Type 1. Diabetes Care 2008: 31: 528-533.
16. Moran A, Jacobs DR Jr, Steinberger J et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation 2008: 117: 2361-2368.
17. Ma X, Becker D, Arena V, Vicini P, Greenbaum C. The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of Type 1 Diabetic Patients: a population analysis. J Clin Endocrinol Metab 2009: 94: 2446-2451.